Saballa, Shiela .
HRN: 03-63-43 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/13/2025
07/19/2025
IV
500mg
Q6
AGE
Checking Initial Appropriateness